F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:F1 Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11119
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring the molecular circuitry of the immune system to target some of the most challenging solid tumor malignancies. It has operational presence in San Diego, California, Cayman Islands, Hong Kong and Shanghai. F1 Oncology is headquartered in West Palm Beach, Florida, the US.

F1 Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
F1 Oncology Raises USD40 Million in Venture Financing 10
Partnerships 11
F1 Oncology and Shanghai Sinobioway Sunterra Biotechnology Enter into Agreement 11
Licensing Agreements 12
F1 Oncology Enters into Licensing Agreement with BioAtla 12
Equity Offering 13
F1 Oncology Raises USD10 Million in Private Placement of Shares 13
F1 Oncology Inc – Key Competitors 14
F1 Oncology Inc – Key Employees 15
F1 Oncology Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
F1 Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F1 Oncology Raises USD40 Million in Venture Financing 10
F1 Oncology and Shanghai Sinobioway Sunterra Biotechnology Enter into Agreement 11
F1 Oncology Enters into Licensing Agreement with BioAtla 12
F1 Oncology Raises USD10 Million in Private Placement of Shares 13
F1 Oncology Inc, Key Competitors 14
F1 Oncology Inc, Key Employees 15
F1 Oncology Inc, Other Locations 16

List of Figures
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SeraCare Life Sciences, Inc.-医療機器分野:企業M&A・提携分析
    Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products i …
  • Nutritional Resources Inc:企業の戦略・SWOT・財務情報
    Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report Summary Nutritional Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • Tyco International plc:企業のM&A・事業提携・投資動向
    Tyco International plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tyco International plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Arab International Bank
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Crescent Point Energy Corp (CPG):石油・ガス:M&Aディール及び事業提携情報
    Summary Crescent Point Energy Corp (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and natu …
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Allena Pharmaceuticals Inc (ALNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Allena Pharmaceuticals Inc (Allena) is a developer of oral enzyme therapeutics to treat patients with rare and severe metabolic disorders. The company develops ALLN-177, an oral recombinant oxalate degrading enzyme. It provides ALLN-177 which is developed for the chronic management of hypero …
  • Delta NV-エネルギー分野:企業M&A・提携分析
    Summary Delta N.V. (Delta) is an independent multi-utility company. It provides energy, network and infrastructure services, and digital services. The company generates electricity, transmits and trades in energy, and supplies gas and power. Delta provides cable services for both analogue and digita …
  • Livzon Pharmaceutical Group Co Ltd (000513):企業の財務・戦略的SWOT分析
    Summary Livzon Pharmaceutical Group Co Ltd (Livzon) a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and in …
  • Orange SA:企業の戦略・SWOT・財務情報
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • BellBrook Labs LLC-医療機器分野:企業M&A・提携分析
    Summary BellBrook Labs LLC (BellBrook) is a medical device company that develops detection reagents and screening tools. The company’s biochemical assay technology offers UVO microconduit array platform, chemotaxis assay plate, transcreener HTS assays, ADP² assays, AMP² and GMP² assays, GDP assays, …
  • Nurix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Ariba Inc:企業の戦略的SWOT分析
    Ariba Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Republic National Distributing Co:企業の戦略・SWOT・財務情報
    Republic National Distributing Co - Strategy, SWOT and Corporate Finance Report Summary Republic National Distributing Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SFS Group AG:企業の戦略・SWOT・財務分析
    SFS Group AG - Strategy, SWOT and Corporate Finance Report Summary SFS Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Selex Gruppo Commerciale S.p.A.:企業の戦略・SWOT・財務情報
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆